FutureHealth Podcast Series

THE COWEN INSIGHT

Cowen explores the convergence of health care, technology, and consumerism and how it changes the way we look at health care at our annual FutureHealth Conference. We bring together thought-leaders, innovators and investors across sectors to get the most up-to-date views on the current landscape.

In conjunction with this year’s conference, our analysts speak with several leaders in the space. We share these conversations in a six-part podcast series.

Episode 1: Welldoc – Anand Iyer, Chief Strategy Officer

Cowen Host: Charles Rhyee, Health Care Services Analyst

Digital therapeutics hold the potential for a new class of drugs with software as the therapeutic agent. In this podcast, we speak with Anand Iyer, Chief Strategy Officer of Welldoc. Mr. Ieyer played a key role in the development of Welldoc’s BlueStar, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. 

They discuss the adoption of digital therapeutics, challenges to achieving a successful commercial model, and COVID-19’s impact on consumer and physician readiness to adopt telehealth and digital care.

Press play below to listen to their conversation.

Episode 2: Click Therapeutics – David Klein, Co-Founder and CEO

Cowen Host: Charles Rhyee, Health Care Services Analyst

In this episode, we continue the discussion around digital therapeutics with David Klein, Co-Founder and CEO of Click Therapeutics. Click Therapeutics develops software for mobile phones that uses cognitive and neurobehavioral mechanisms for medical treatment. 

They discuss partnerships, the effect of regulators and payer reimbursement on the market, and paths to commercialization.

Press play below to listen to their conversation.

Episode 3: Evidation Health – Deborah Kipatrick, CEO

Cowen Host: Charles Rhyee, Health Care Services Analyst

In this episode, we talk about data. The biopharma industry, which has always valued and sought out new forms of data has increasingly started looking outside the controlled environment of clinical trials to find data from the real world. One newer form of real-world evidence is everyday behavior data.

We’re joined by Deborah Kilpatrick, CEO of Evidation Health to help us explore this topic. Evidation is a new kind of health and measurement company that focuses on capturing and measuring everyday behavior data, which is proving to be an exceptionally powerful lens on health. 

They discuss privacy and permission for use of data streams, partnerships in pharma, medtech and technology, and how Evidation is helping research the impact of and susceptibility to COVID-19.

Press play below to listen to their conversation.

Episode 4: Glooko – Russ Johannesson, CEO

Cowen Host: Ryan Blicker, Life Science & Diagnostic Tools Analyst

Diabetes devices is an industry with exciting long term secular growth. To help us discuss the future of digital diabetes care, we’re joined by Russ Johannesson, CEO of Glooko.

Glooko is a SaaS software for diabetes management, enabling seamless aggregation/management of data from various diabetes devices, and increasingly, providing adjacent services to physicians.

They discuss market opportunity and penetration, evolution of the product offering, the competitive landscape, and how partnerships help with Glooko’s long term vision.

Press play below to listen to their conversation.

Episode 5: Saama Technologies – Suresh Katta, Founder and CEO and Greg Simpson, VP and Head of Marketing

Cowen Host: Charles Rhyee, Health Care Services Analyst

In this episode, we discuss AI-powered data and analytics in clinical development

In the digital age, data and analytics are being applied to just about everything, nowhere more than drug development. The biopharma space is always looking for ways to accelerate and optimize the clinical development process.

We speak with Suresh Katta, Founder and CEO, along with Greg Simpson VP and Head of Marketing, of Saama Technologies. Saama Technologies is a clinical data analytics company that leverages AI to integrate, curate and animate structured, unstructured and real-world data to deliver actionable insights for biopharma.

In this episode they discuss….

Press play below to listen to their conversation.